Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
REVVITY, INC. via REVVITY, INC.
2026 · third_quarter · Q3
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2026 · second_quarter · Q2
Source: Senate LDA
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: REVVITY, INC. · Firm: REVVITY, INC.
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: REVVITY, INC. · Firm: REVVITY, INC.
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: REVVITY, INC. · Firm: REVVITY, INC.
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act
Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: REVVITY, INC. · Firm: REVVITY, INC.
Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2026 · first_quarter · Q1
Support for Genetic Screening Proposals related to pandemic preparedness
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REVVITY, INC. via REVVITY, INC.
2025 · fourth_quarter · Q4
Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2025 · third_quarter · Q3
Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Medical Device & Pharmaceutical Adjacent Tariff
Filing targets: Bureau of Industry and Security (BIS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2025 · second_quarter · Q2
Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act
Medical Device & Pharmaceutical Adjacent Tariff
Filing targets: Bureau of Industry and Security (BIS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · first_quarter · RA
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs.